CARDIOLOGY
Move your cardiology compound from preclinical to early clinical efficiently, with a CRO that has worked on 30 different cardiology compounds across more than 70 studies. We can quickly de-risk your molecule with preclinical cardiovascular studies and with early cardiac safety assessment in early clinical studies.
Our preclinical and clinical experience spans a wide range of cardiology indications, including arrhythmias, hypertension, dyslipidemias, and congestive heart failure. Preclinical programs can be conducted across different species with robust safety pharmacology cardiovascular studies. Our preclinical facility has a specially designed room for ECG monitoring by telemetry. Our clinics are equipped with telemetry and staffed by a trained cardiac team.
Types of Cardiology Trials:
- Drug Trials: Evaluate the safety and efficacy of new medications for various cardiovascular conditions, such as hypertension, heart failure, or arrhythmias.
- Device Trials: Assess the effectiveness and safety of new medical devices, such as stents, pacemakers, or implantable defibrillators.
- Interventional Trials: Investigate the impact of specific interventions, such as lifestyle modifications, diet, or exercise, on cardiovascular health.
- Prevention Trials: Focus on strategies to prevent the development or progression of cardiovascular diseases, including studies on risk factor modification.
Endpoints:
- Common endpoints in cardiology trials include cardiovascular events (e.g., heart attacks, strokes), improvement in symptoms, quality of life, and survival rates.